Latest Annual General Meeting News

GALE Pacific reported a slight revenue dip and a net loss in FY25, driven by US market challenges including tariffs and weak consumer demand. The company is now overhauling its US operations and diversifying manufacturing to restore profitability.

Wellard Ltd posts a net profit turnaround in FY2025 despite fleet downsizing, sells its last vessel, and plans to delist from the ASX while returning substantial capital to shareholders.

Ariadne Australia Limited reported a remarkable 409% jump in pre-tax profit for FY25, alongside a 38% revenue increase, yet faced a sharp decline in comprehensive income. The company declared a partially franked final dividend, signaling confidence amid mixed financial signals.

Pure Hydrogen Corporation has raised A$1 million through a share placement with attaching options, aiming to accelerate its clean energy projects across Australia and the US.

WAM Alternative Assets reported modest profit growth for FY2025, raised its fully franked final dividend by 15.4%, and outlined a strategic shift towards growth investments in its diversified alternative assets portfolio.

Lachlan Star Limited has raised $2.162 million through a share placement to fund critical drilling programs at its gold and copper projects in Western Australia and New South Wales.

Lifestyle Communities Limited has reported a sharp downturn for FY2025, with revenues plunging nearly 39% and a net loss soaring to $195 million, leading to a suspension of dividends.

Wesfarmers has announced a $1.50 per share capital management initiative, combining a $1.10 return of capital with a $0.40 fully-franked special dividend, pending shareholder approval at the upcoming AGM.

Wesfarmers Limited reported a robust 2025 financial year with a 14.4% increase in net profit after tax to $2.926 billion and declared fully franked dividends of $2.06 per share. The conglomerate also unveiled a proposed $1.50 per share capital management distribution, pending shareholder approval.

MotorCycle Holdings Limited reported a robust 11.6% revenue increase and a 27.5% jump in profit after tax for FY25, announcing a fully franked 5 cent final dividend.

Cambium Bio has updated its placement, raising A$2.17 million to fund late-stage clinical trials for its lead ophthalmology product, Elate Ocular®. The capital raise reflects strong investor interest and strategic backing.

MRG Metals has successfully raised over $500,000 through an entitlement offer, issuing new options to fund exploration in Mozambique while directors fully subscribed and plan further participation.